Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial-Reference-Cited by-同舟云学术

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

Published:2017-03-01 Issue:3 Volume:152 Page:224
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Solomkin Joseph¹,Evans David²,Slepavicius Algirdas³,Lee Patrick⁴,Marsh Andrew⁵,Tsai Larry⁵,Sutcliffe Joyce A.⁵,Horn Patrick⁵

Affiliation:

1. University of Cincinnati College of Medicine, Cincinnati, Ohio

2. Ohio State University School of Medicine, Columbus

3. Klaipeda University Hospital, Klaipeda, Lithuania

4. Baystate Medical Center, Springfield, Massachusetts

5. Tetraphase Pharmaceuticals Inc, Watertown, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Surgery

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis;Expert Review of Anti-infective Therapy;2024-09-11

2. On the assessment of the role of new antibiotics in pharmacotherapy algorithms for complicated intra-abdominal infections (literature review);Journal of Volgograd State Medical University;2024-08-05

3. The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection: 2024 Update;Surgical Infections;2024-08-01

4. Third-Generation Tetracyclines: Current Knowledge and Therapeutic Potential;Biomolecules;2024-06-30

5. Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations;International Journal of Molecular Sciences;2024-06-21